Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -71.43% is 35% above its 5-year average of -109.74%, near the high end of its 5-year range (-239.92%–-10.93%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.18% above its 12-month average of -159.36%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -71.43%.
RETURN ON INVESTED CAPITAL (ROIC)
-71.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-159.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-133.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-109.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+55.18%
CURRENT VS 3Y AVG
+46.66%
CURRENT VS 5Y AVG
+34.91%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-100.38%
vs the sector median at left
XORTX Therapeutics Inc.
Market Cap
$484571.00
Return on Invested Capital (ROIC)
-71.43%
TTM Avg
-159.36%
3Y Avg
-133.92%
5Y Avg
-109.74%
Market Cap
$530421.00
Return on Invested Capital (ROIC)
-579.89%
TTM Avg
-179.78%
3Y Avg
-200.54%
5Y Avg
-146.84%
Market Cap
$563178.00
Return on Invested Capital (ROIC)
-41.92%
TTM Avg
-267.75%
3Y Avg
-175.00%
5Y Avg
-127.51%
Market Cap
$381940.00
Return on Invested Capital (ROIC)
-10.38%
TTM Avg
-17.82%
3Y Avg
-53.65%
5Y Avg
-61.91%
Market Cap
$380715.00
Return on Invested Capital (ROIC)
-83.46%
TTM Avg
-94.98%
3Y Avg
-93.88%
5Y Avg
-93.88%
Market Cap
$678241.00
Return on Invested Capital (ROIC)
4.47%
TTM Avg
-1129.41%
3Y Avg
-780.32%
5Y Avg
-986.52%
Market Cap
$245237.00
Return on Invested Capital (ROIC)
-152.82%
TTM Avg
-117.29%
3Y Avg
-102.27%
5Y Avg
-113.28%
Market Cap
$731546.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-19.74%
3Y Avg
-21.30%
5Y Avg
-19.67%
Market Cap
$827005.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-3.54%
3Y Avg
-13.19%
5Y Avg
-11.55%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| XORTX Therapeutics Inc. (XRTX) | $484571.00 | -71.43% | -159.36% | -133.92% | -109.74% |
| VivoSim Labs, Inc. (VIVS)vs › | $530421.00 | -579.89% | -179.78% | -200.54% | -146.84% |
| HCW Biologics Inc. (HCWB)vs › | $563178.00 | -41.92% | -267.75% | -175.00% | -127.51% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | -10.38% | -17.82% | -53.65% | -61.91% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | -83.46% | -94.98% | -93.88% | -93.88% |
| CDT Equity Inc. (CDT)vs › | $678241.00 | 4.47% | -1129.41% | -780.32% | -986.52% |
| SciSparc Ltd. (SPRC)vs › | $245237.00 | -152.82% | -117.29% | -102.27% | -113.28% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $731546.00 | N/A | -19.74% | -21.30% | -19.67% |
| Ridgetech, Inc. (RDGT)vs › | $827005.00 | N/A | -3.54% | -13.19% | -11.55% |
| Decoy Therapeutics Inc. (DCOY)vs › | $840509.00 | -343.55% | -272.49% | -270.70% | -191.72% |
ROIC
-71.4%
ROE
-68.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -71.43% |
| 2026-03-31 | -239.92% |
| 2025-12-31 | -156.71% |
| 2025-09-30 | -162.75% |
| 2025-06-30 | -166.00% |
| 2025-03-31 | -144.98% |
| 2024-12-31 | -122.87% |
| 2024-09-30 | -209.40% |
| 2024-06-30 | -116.57% |
| 2024-03-31 | -92.44% |
| 2023-12-31 | -131.34% |
| 2023-09-30 | -123.34% |
| 2023-06-30 | -109.20% |
| 2023-03-31 | -98.46% |
| 2022-12-31 | -123.77% |
| 2022-09-30 | -124.19% |
| 2022-06-30 | -77.03% |
| 2022-03-31 | -31.02% |
| 2021-12-31 | -10.93% |
| 2021-06-30 | -12.55% |
| 2021-03-31 | -9.81% |
| 2020-12-31 | -27.48% |
| 2020-09-30 | -8.37% |
| 2020-06-30 | -21.00% |
| 2020-03-31 | -22.34% |
| 2019-06-30 | -946.86% |
| 2019-03-31 | -345.25% |
| 2018-12-31 | -268.22% |
| 2018-09-30 | -217.48% |
| 2018-06-30 | -119.19% |
